Loading...
XSHE
000705
Market cap355mUSD
Oct 09, Last price  
7.22CNY
1D
1.40%
1Q
16.08%
Jan 2017
-44.76%
Name

Zhejiang Zhenyuan Share Co Ltd

Chart & performance

D1W1MN
XSHE:000705 chart
P/E
106.31
P/S
1.06
EPS
0.07
Div yield, %
0.84%
Shrs. gr., 5y
-0.42%
Rev. gr., 5y
-7.93%
Revenues
2.28b
-39.17%
954,582,9101,112,773,6041,276,037,7011,503,278,7151,719,497,2441,812,211,1142,018,147,6442,081,233,1392,165,277,4702,440,003,8912,577,916,0462,858,058,6253,243,149,4113,243,149,4103,439,840,4403,612,045,2544,145,479,3044,106,371,5943,740,688,4692,275,611,149
Net income
23m
-34.66%
7,729,82412,244,51817,791,33021,072,40531,536,13347,672,70664,438,12639,078,86533,535,61145,275,58461,082,49770,884,111211,570,678211,570,68089,392,93877,295,07777,909,26981,642,56834,729,26222,692,235
CFO
41m
-46.60%
48,743,35248,384,36331,792,46026,217,24149,076,3800126,488,86217,390,49781,407,56756,744,630115,993,13351,721,83225,488,980118,359,124154,814,64075,165,175090,819,92776,095,42740,634,241
Dividend
Jun 27, 20250.06 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Based in Shaoxing, China, Zhejiang Zhenyuan Share Co., Ltd. is a pharmaceutical entity with operations extending across China and into global markets. Established in 1752, the company provides a wide array of pharmaceutical offerings. These include various traditional Chinese medicines (such as patent medicines, raw materials, and herbal preparations), alongside modern chemical preparations, active pharmaceutical ingredients, biochemical compounds, anesthetics, psychotropic drugs, medical equipment, and chemical reagents. Its diverse product line is marketed under the Zhenyuan and Zhenyuantang brand names. The firm primarily caters to the pharmaceutical commerce and health service industries.

Key people

Haiming Wu
Executive Chairman of the Board · since 2025
Yufeng Zhang
Secretary of the Board · since 2025
Xiaochun Fu
Director · since 2023
Yuhua Lou
Deputy General Manager, Director · since 2024
Zhanyi Qian
Deputy General Manager, Director · since 2024
Hao Wang
Deputy General Manager, Staff Elected Director · since 2023
Min Wei
Deputy General Manager, Director · since 2022
Yuemei Zhou
Director · since 2020
Jian Feng
Independent Director · since 2023
Suhua Hu
Independent Director · since 2023
Hongwei Wang
Independent Director · since 2023
Jianwei Yuan
Independent Director · since 2023
IPO date
Apr 10, 1997
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122020‑002019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT